DIFFERENTIATION OF AUTOIMMUNE OPHTHALMOPATHY FROM GRAVES’HYPERTHYROIDISM BY ANALYSIS OF GENETIC MARKERS
暂无分享,去创建一个
P. Perros | P. Kendall‐Taylor | S. Papiha | A. Stratton | A. Stephenson | D. Roberts | Papiha Ss | S. S. PAPIHA | D. F. Roberts | Petros Perros | Pat Kendall-Taylor | D. F. Roberts
[1] J. Rock,et al. The association of anti‐P and early abortion , 1987, Transfusion.
[2] R. Fauchet,et al. HLA immunogenetic heterogeneity in black American patients with Graves' disease. , 1987, Archives of internal medicine.
[3] N. Farid,et al. GENETIC FACTORS IN GRAVES' OPHTHALMOPATHY , 1986, Clinical endocrinology.
[4] J. Lanchbury,et al. Genetic structure of the population with rheumatoid arthritis in north east England: a genetic approach to define different subtypes. , 1986, Annals of the rheumatic diseases.
[5] C. Rotella,et al. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. , 1986, The Journal of clinical endocrinology and metabolism.
[6] P. Kendall‐Taylor. 2 The pathogenesis of graves' ophthalmopathy , 1985 .
[7] N. Farid,et al. IDENTIFICATION OF SUBSETS OF PATIENTS WITH GRAVES’DISEASE BY CLUSTER ANALYSIS , 1983, Clinical endocrinology.
[8] W. Mayr,et al. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. , 1983, The Journal of clinical endocrinology and metabolism.
[9] R. J. Mitchell,et al. Genetic structure in Cumbria , 1981, Journal of Biosocial Science.
[10] N. Farid,et al. The human major histocompatibility complex and endocrine disease. , 1981, Endocrine reviews.
[11] C. Gorman. The presentation and management of endocrine ophthalmopathy. , 1978, Clinics in endocrinology and metabolism.
[12] J. Nerup,et al. HLA antigens in Graves' disease. , 1977, Acta endocrinologica.
[13] W. Mayr,et al. Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy. , 1977, Diabete & metabolisme.
[14] D. Evered,et al. THYROID‐STIMULATING IMMUNOGLOBULINS IN OPHTHALMIC GRAVES'DISEASE , 1977, Clinical endocrinology.
[15] D. N. Raine,et al. Handbook of Enzyme Electrophoresis in Human Genetics , 1977 .
[16] D. Solomon,et al. Identification of subgroups of euthyroid graves's ophthalmopathy. , 1977, The New England journal of medicine.
[17] W. Mayr,et al. HLA CW3 in thyrotoxicosis patients with and without endocrine ophthalmopathy. , 2008, Tissue antigens.
[18] J. Nam,et al. Bernstein's and gene‐counting methods in generalized ABO‐like systems , 1976, Annals of human genetics.
[19] J. Konishi,et al. HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. , 1974, The Journal of clinical endocrinology and metabolism.
[20] J. Dausset,et al. Studies on the Biosynthetic Pathway of Human P Erythrocyte Antigens Using Somatic Cells in Culture , 1974, Vox sanguinis.
[21] J. Sisson,et al. The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts. , 1973, The Journal of clinical endocrinology and metabolism.
[22] S C Werner,et al. Classification of the eye changes of Graves' disease. , 1969, American journal of ophthalmology.
[23] C. Alper,et al. Genetic polymorphism of the third component of human complement (C'3). , 1968, The Journal of clinical investigation.
[24] G. Leigheb,et al. SURVIVAL OF TEST SKIN GRAFTS IN MAN: EFFECT OF GENETIC RELATIONSHIP AND OF BLOOD GROUPS INCOMPATIBILITY * , 1966 .
[25] O. Smithies,et al. Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. , 1955, The Biochemical journal.